Delivery Order SPE2DE24D0021-SPE2D626F03ER
- Not listed
- The Department of Defense Medical Supply Chain awarded a delivery order valued at $2,200 to Fisher Scientific Company L.L.C. on October 28, 2025, for Sofia 2 Flu + SARS antigen fluorescent diagnostic test kits. The contract, which operates under a fixed-price structure with economic price adjustment provisions, is scheduled for completion by December 26, 2025, and will be performed in Pittsburgh, Pennsylvania. This delivery order represents a child contract issued under a larger procurement...
- The Department of Defense's Medical Supply Chain awarded a delivery order valued at $3,850 to Fisher Scientific Company L.L.C. on January 9, 2026, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. The contract, which operates as a child of a larger General Services Administration Multiple Award Schedule (MAS) vehicle, carries an ultimate completion date of March 10, 2026, and utilizes fixed-price pricing with economic price adjustment terms. This delivery order represents a...
- The Department of Defense Medical Supply Chain awarded a $2,200 delivery order to Fisher Scientific Company L.L.C. on December 1, 2025, for SOFIA 2 FLU + SARS antigen fluorescent diagnostic test kits. The contract is a fixed-price agreement with economic price adjustment provisions and extends through January 29, 2026. Performance will occur at Fisher Scientific's location in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger federal procurement vehicle,...
- The Department of Defense's Medical Supply Chain awarded Fisher Scientific Company L.L.C. a delivery order valued at $2,200 for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits, with an ultimate completion date of January 5, 2026. This fixed-price delivery order with economic price adjustment carries no set-aside designation, indicating open competition. The award was issued on November 4, 2025, and performance will take place at Fisher Scientific's facility in Pittsburgh,...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $3,300 for the supply of SOFIA 2 FLU + SARS antigen fluorescent diagnostic test kits under a fixed-price contract with economic price adjustment. The award, issued on December 3, 2025, with an ultimate completion date of February 2, 2026, was made by the Department of Defense's Medical Supply Chain. Performance will occur in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger...
- The Department of Defense's Medical Supply Chain has awarded a delivery order valued at $2,100 to Fisher Scientific Company L.L.C. for SOFIA Flu AB Test Kits (25 tests per pack). This fixed-price contract with economic price adjustment provisions was awarded on November 13, 2025, with an ultimate completion date of November 20, 2025, and will be performed in Pittsburgh, Pennsylvania. The award carries no set-aside designation, indicating it was competitively procured in an open environment. This...
- The Department of Defense Medical Supply Chain awarded a delivery order valued at $1,100 to Fisher Scientific Company L.L.C. on December 19, 2025, for SOFIA 2 Flu + SARS antigen fluorescent immunoassay test kits. The contract is fixed-price with economic price adjustment provisions and represents a child order under a larger indefinite delivery vehicle. Performance will be completed by February 19, 2026, at Fisher Scientific's facility in Pittsburgh, Pennsylvania. This award was made without a...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $5,500 for the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits by the Department of Defense's Medical Supply Chain. The contract is a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of March 12, 2026. The order will be fulfilled from Fisher Scientific's principal place of business in Pittsburgh, Pennsylvania. This delivery order...
- Fisher Scientific Company L.L.C. received a delivery order award from the Department of Defense's Medical Supply Chain on January 12, 2026, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. This fixed-price delivery order with economic price adjustment carries a ceiling value of $2,764.60 and represents a child contract under a larger procurement vehicle. The work will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of March 11, 2026. No set-aside...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,200 by the Department of Defense's Medical Supply Chain on December 4, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. The contract is a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of February 3, 2026. The award is a child contract under a larger vehicle and required no set-aside designation, indicating open competition. Performance...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F03ERDelivery Order
The Department of Defense Medical Supply Chain awarded a $3,317.52 fixed-price delivery order to Fisher Scientific Company L.L.C. on January 12, 2026, for Sofia 2 Flu + SARS antigen fluorescent diagnostic test kits. The contract, which represents a child award under a larger procurement vehicle, will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of March 11, 2026. This delivery order was not issued under a set-aside designation, indicating competition in the open federal marketplace. Fisher Scientific, a major federal vendor specializing in laboratory equipment and medical supplies, has established itself as a critical supplier to the Department of Defense and other federal agencies through its registered status in the System for Award Management since 2001. This award supports the Defense Department's medical supply chain operations, which rely on Fisher Scientific's extensive capabilities in providing diagnostic equipment and test kits across multiple military healthcare facilities. The Sofia 2 multiplex antigen test represents a rapid diagnostic tool for concurrent detection of influenza and SARS-CoV-2, supporting clinical operations and disease surveillance requirements within the military medical system. Fisher Scientific's federal contract portfolio demonstrates consistent success in competing for laboratory and medical supply awards, including previous delivery orders for diagnostic test kits, biosafety equipment, and specialized reagents. The fixed-price structure with economic price adjustment provides cost certainty while maintaining flexibility for market-based adjustments during the contract performance period.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 1/11/26 |